Transdermal delivery of cyclosporin-A using electroporation

Journal of Controlled Release

Volumn 50, Issue 1-3, 1998, Pages 61-70

  Wang, Su ^a   Kara, M ^a   Krishnan, T R ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Cyclosporin A; Electroporation; Ethanol; Transdermal delivery

Indexed keywords

ALCOHOL; CYCLOSPORIN A;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFUSION; DRUG FORMULATION; DRUG PENETRATION; DRUG TRANSPORT; ELECTROPORATION; IONTOPHORESIS; MALE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; SKIN PERMEABILITY;

ADMINISTRATION, CUTANEOUS; ANIMALS; CYCLOSPORINE; DRUG DELIVERY SYSTEMS; ELECTROPORATION; IMMUNOSUPPRESSIVE AGENTS; IONTOPHORESIS; RATS; SKIN;

EID: 0032472341     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(97)00117-X     Document Type: Article

References (37)

1. B.W. Barry, Dermatological Formulations: Percutaneous Absorption, Marcel Dekker, Inc., New York and Basel, 1983, pp. 181-182.
2. Guy R.H., Hadgraft J. Transdermal drug delivery: the ground rules are emerging. Pharm. Int. 6:1985;112.
3. Wertz P.W., Abraham W., Landmann L., Downing D.T. Preparation of liposomes from stratum corneum lipids. J. Invest. Dermatol. 87:1986;582-584.
4. Elias P.M. Epidermal lipids, barrier function, and desquamation. J. Invest. Dermatol. 80:1983;40-49.
5. Sznitawska M., Berner B., Maibach H.I. Percutaneous penetration of multipolar ions: evidence for porous transport. Int. J. Pharm. 123:1995;41-45.
6. Sheuplein R.J., Blank I.H. Permeability of the skin. Physiol. Rev. 51:1971;702-747.
7. Brown L., Langer R. Transdermal delivery of drugs. Ann. Rev. Med. 39:1988;221-229.
8. Prausnitz M.R., Bose V.G., Langer R., Weaver J.C. Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc. Natl. Acad. Sci. USA. 90:1993;10504-10508.
9. Prausnitz M.R., Pliquett U., Langer R., Weaver J.C. Rapid temporal control of transdermal drug delivery by electroporation. Pharm. Res. 11(12):1994;1834-1837.
10. Vanbever R., Morre N.D., Preat V. Transdermal delivery of fentanyl by electroporation II. Mechanisms involved in drug transport. Pharm. Res. 13(9):1996;1360-1366.
11. Bommannan D.B., Tamada J., Leung L., Potts R.O. Effect of electroporation on transdermal iontophoretic delivery of Luteinizing Hormone Releasing Hormone (LHRH) in vitro. Pharm. Res. 11(12):1994;809-1814.
12. Edwards D.A., Prausnitz M.R., Langer R., Weaver J.C. Analysis of enhanced transdermal transport by skin electroporation. J. Control. Release. 34:1995;211-221.
13. Pliquett U., Weaver J.C. Transport of a charged molecule across the human epidermis due to electroporation. J. Control. Release. 38:1996;1-10.
14. E. Neumann, A. Sprafke, E. Boldt, H. Wolf, Biophysical consideration of membrane electroporation, in: D. Chang, B. Chassy, J. Saunders, A. Sowers (Eds.), Guide to Electroporation and Electrofusion, Academic Press Inc., New York, 1992, pp. 77-90.
15. Neumann E., Schaefer-Ridder M., Wang Y., Hofscheider P.H. EMBO J. 1:1982;841-845.
16. Sowers A.S., Lieber M.R. Electropore diameters, lifetimes, numbers and location in individual erythrocyte ghosts. FEBS Lett. 205:1986;179-184.
17. Sokoloski J.A., Jastreboff M.M., Bertino J.R., Sartorelli A.C., Narayanan R. Introduction of deoxyribonucleotide triphosphate into intact cells by electroporation. Anal. Biochem. 158:1986;272-277.
18. Mir L.M., Orlowski S., Belehradek J. Jr., Paoletti C. Electrochemotherapy potentiation of antitumor effect of bleomycin by local electric pulses. Eur. J. Cancer. 27(1):1991;68-72.
19. Heller R., Jaroszeski M.J., Glass L.F., Messina J.L., Rapapart D.P., DeConti R.C., Fenske N.A., Gilbert R.A., Mir L.M., Reintgen D.S. Phase I/II trial for the treatment of cutaneous and sub cutaneous tumors using electrochemotherapy. Cancer. 77(5):1996;964-971.
20. Powell K.T., Morgenthaler A.W., Weaver J.C. Tissue electroporation: observation of reversible electrical breakdown in viable frog skin. Biophys. J. 57:1989;1163-1171.
21. D.C. Chang, T.S. Reese, Structure and dynamics of electric field induced membrane pore as revealed by rapid freezing electron microscopy, in: D.C. Chang, B. Chassy, J. Saunders, A. Sowers (Eds.), Guide to Electroporation and Electrofusion, Academic Press Inc., New York, 1992, pp. 9-27.
22. Weaver J.C. Electroporation: a general phenomenon for manipulating cells and tissues. J. Cell. Biochem. 51:1993;426-435.
23. Dimitrov D.S., Sowers A. Membrane electroporation-fast molecular exchange by electroosmosis. Biochim. Biophys. Acta. 1022:1990;381-392.
24. J.C. Weaver, Electroporation theory, in: J.A. Nickoloff (Ed.), Methods in molecular biology, Vol. 48, Humana Press Inc., Totowqa, NJ, 1995, pp. 3-63.
25. Bos J.D., Joost T.V., Powels A.V., Meinard M.M.H.M., Heule F., Fry L. Use of cyclosporin in psoriasis. Lancet. 30:1989;1500-1502.
26. Griffiths C.E.M. Systemic and local administration of cyclosporin in the treatment of psoriasis. J. Am. Acad. Dermatol. 23:1990;1242-1247.
27. Pikal M.J. The role of electroosmosis flow on transdermal iontophoresis. Adv. Drug Deliv. Rev. 9:1992;201-237.
28. Pliquett U., Langer R., Weaver J.C. Changes in the passive electrical properties of human stratum corneum due to electroporation. Biochim. Biophys. Acta. 1239:1995;111-121.
29. USP XXII, Cyclosporin, United States Pharmacopoeial Convention Inc., Rockville, MD, 1990, p. 371.
30. Egbaria K., Ramachandran C., Weiner N. Topical application of liposomally entrapped cyclosporin evaluated by in vitro diffusion studies with human skin. Skin Pharmacol. 4:1991;21-28.
31. Duncan J.I., Wakeel R.A., Winfield A.J., Ormerod A.D., Thomson A.W. Immunomodulation of psoriasis with a topical cyclosporin A formulation. Acta Derm.-Venereol. 73(2):1993;84-87.
32. Choi H.K., Flynn G.L., Amidon G.L. Percutaneous absorption and dermal delivery of cyclosporin A. J. Pharm. Sci. 84(5):1995;581-583.
33. Tayar N.E., Mark A.E., Vallat P., Brunne R.M., Testa B., van Gunstern W.F. Solvent-dependent conformation and hydrogen-bonding capacity of cyclosporin A: evidence from partition coefficients and molecular dynamics simulations. J. Med. Chem. 36:1993;3757-3764.
34. Prausnitz M.R. The effects of electric current applied to skin: A review for transdermal delivery. Adv. Drug Deliv. Rev. 18:1996;395-425.
35. Pliquett U.F., Zewert T.E., Chen T., Langer R., Weaver J.C. Imaging of fluorescent molecule and small ion transport through human stratum corneum during high voltage pulsing: localized transport regions are involved. Biophys. Chem. 58:1996;185-204.
36. Biren C., Ganderup G., Lemus L., McCullough J., Barr R. Topical cyclosporin (CSA): effect on contact dermatitis in guinea pigs. J. Invest. Dermatol. 82:1984;419.
37. B.W. Barry, Vehicle effect: What is an enhancer? in: V.P. Shah, H. Maibach (Eds.), Topical Drug Bioavailability, Bioequivalence and Penetration, Plenum Press, New York, 1993, pp. 261-276.